Zenith Suspension: For the treatment of the following infections caused by microorganisms sensitive to azithromycin (see Precautions and Pharmacology: Pharmacodynamics under Actions): Upper respiratory tract infections, including sinusitis, pharyngitis, tonsillitis; Lower respiratory tract infections, including bronchitis and pneumonia; Acute otitis media; Skin and soft tissue infections; Uncomplicated genital infections caused by Chlamydia trachomatis or Neisseria gonorrhoeae (non-multi-resistant strains).
Considerations should be given to official guidance on the appropriate use of antibacterial agents.
Zenith OD Suspension: For the treatment of the following mild to moderate infections caused by susceptible microorganisms: Lower respiratory tract infections: Acute bacterial bronchitis UK; Community-acquired pneumonia (CAP) in patients suitable for outpatient oral treatment. [Note: Azithromycin should not be administered to patients with moderate to severe pneumonia or when there are risk factors that make oral therapy inappropriate (see Precautions)].
Upper respiratory tract infections: Acute bacterial sinusitis; Acute otitis media; Acute streptococcal pharyngitis or tonsillitis (as second-line treatment).
Note: Penicillin is usually the drug of choice for the treatment of streptococcal pharyngitis/tonsillitis and also for prophylaxis of acute rheumatic fever. Azithromycin appears to be as effective as penicillin against streptococcus in the oropharynx, however, the efficacy of azithromycin in the subsequent prevention of rheumatic fever has not been established.
Uncomplicated skin and skin structure infections.
Chlamydia trachomatis conjunctivitis and trachoma.
Other Services
Country
Support
Account
Sign Out